Significant clinical response of progressive recurrent ovarian clear cell carcinoma to glypican-3-derived peptide vaccine therapy: Two case reports

by Suzuki, Shiro, Suzuki, Shiro, Shibata, Kiyosumi, Shibata, Kiyosumi, Kikkawa, Fumitaka, Kikkawa, Fumitaka, Nakatsura, Tetsuya, Nakatsura, Tetsuya
Published 2014

Peptide vaccines for hepatocellular carcinoma

by Nobuoka, Daisuke, Yoshikawa, Toshiaki, Sawada, Yu, Fujiwara, Toshiyoshi, Nakatsura, Tetsuya
Published 2013

A glypican-3-derived peptide vaccine against hepatocellular carcinoma

by Sawada, Yu, Sakai, Mayuko, Yoshikawa, Toshiaki, Ofuji, Kazuya, Nakatsura, Tetsuya
Published 2012

Identification of a novel HLA-A*02:01-restricted cytotoxic T lymphocyte epitope derived from the EML4-ALK fusion gene

by YOSHIMURA, MAYUKO, TADA, YOSHITAKA, OFUZI, KAZUYA, YAMAMOTO, MASAKAZU, NAKATSURA, TETSUYA
Published 2014

Peptide intra-tumor injection for cancer immunotherapy: Enhancement of tumor cell antigenicity is a novel and attractive strategy

by Nobuoka, Daisuke, Yoshikawa, Toshiaki, Fujiwara, Toshiyoshi, Nakatsura, Tetsuya
Published 2013

Critical analysis of the potential of targeting GPC3 in hepatocellular carcinoma

by Ofuji, Kazuya, Saito, Keigo, Yoshikawa, Toshiaki, Nakatsura, Tetsuya
Published 2014

Analysis of cytotoxic T lymphocytes from a patient with hepatocellular carcinoma who showed a clinical response to vaccination with a glypican-3-derived peptide

by TADA, YOSHITAKA, YOSHIKAWA, TOSHIAKI, SHIMOMURA, MANAMI, SAWADA, YU, SAKAI, MAYUKO, SHIRAKAWA, HIROFUMI, NOBUOKA, DAISUKE, NAKATSURA, TETSUYA
Published 201

Identification of an H2-Kb or H2-Db restricted and glypican-3-derived cytotoxic T-lymphocyte epitope peptide

by IWAMA, TATSUAKI, HORIE, KAZUTAKA, YOSHIKAWA, TOSHIAKI, NOBUOKA, DAISUKE, SHIMOMURA, MANAMI, SAWADA, YU, NAKATSURA, TETSUYA
Published 2013

Efficacy of glypican-3-derived peptide vaccine therapy on the survival of patients with refractory ovarian clear cell carcinoma

by Suzuki, Shiro, Sakata, Jun, Utsumi, Fumi, Sekiya, Ryuichiro, Kajiyama, Hiroaki, Shibata, Kiyosumi, Kikkawa, Fumitaka, Nakatsura, Tetsuya
Published 2016

Time-lapse imaging assay using the BioStation CT: A sensitive drug-screening method for three-dimensional cell culture

by Sakamoto, Ruriko, Rahman, M Mamunur, Shimomura, Manami, Itoh, Manabu, Nakatsura, Tetsuya
Published 2015

Large-scale expansion of γδ T cells and peptide-specific cytotoxic T cells using zoledronate for adoptive immunotherapy

by YOSHIKAWA, TOSHIAKI, TAKAHARA, MASASHI, TOMIYAMA, MAI, NIEDA, MIE, MAEKAWA, RYUJI, NAKATSURA, TETSUYA
Published 2014

Programmed death-1 blockade enhances the antitumor effects of peptide vaccine-induced peptide-specific cytotoxic T lymphocytes

by SAWADA, YU, YOSHIKAWA, TOSHIAKI, SHIMOMURA, MANAMI, IWAMA, TATSUAKI, ENDO, ITARU, NAKATSURA, TETSUYA
Published 2014

A peptide antigen derived from EGFR T790M is immunogenic in non-small cell lung cancer

by OFUJI, KAZUYA, TADA, YOSHITAKA, YOSHIKAWA, TOSHIAKI, SHIMOMURA, MANAMI, YOSHIMURA, MAYUKO, SAITO, KEIGO, NAKAMOTO, YASUNARI, NAKATSURA, TETSUYA
Published 2014

Remarkable tumor lysis in a hepatocellular carcinoma patient immediately following glypican-3-derived peptide vaccination: An autopsy case

by Sawada, Yu, Yoshikawa, Toshiaki, Fujii, Satoshi, Mitsunaga, Shuichi, Nobuoka, Daisuke, Mizuno, Shoichi, Takahashi, Mari, Yamauchi, Chisako, Endo, Itaru, Nakatsura, Tetsuya
Published 2013

Suppression of postsurgical recurrence of hepatocellular carcinoma treated with autologous formalin-fixed tumor vaccine, with special reference to glypican-3

by Kawashima, Issei, Kawashima, Yuri, Matsuoka, Yasuo, Fujise, Kiyotaka, Sakai, Hideki, Takahashi, Mari, Yoshikawa, Toshiaki, Nakatsura, Tetsuya, Ishihara, Takeshi, Ohno, Tadao
Published 2015

Expression of Forkhead box M1 in soft tissue leiomyosarcoma: Clinicopathologic and in vitro study using a newly established cell line

by Maekawa, Akira, Kohashi, Kenichi, Setsu, Nokitaka, Kuda, Masaaki, Iura, Kunio, Ishii, Takeaki, Matsunobu, Tomoya, Nakatsura, Tetsuya, Iwamoto, Yukihide, Oda, Yoshinao
Published 2016

Prognostic significance of FOXM1 expression and antitumor effect of FOXM1 inhibition in synovial sarcomas

by Maekawa, Akira, Kohashi, Kenichi, Kuda, Masaaki, Iura, Kunio, Ishii, Takeaki, Endo, Makoto, Nakatsura, Tetsuya, Iwamoto, Yukihide, Oda, Yoshinao
Published 2016

Intratumoral peptide injection enhances tumor cell antigenicity recognized by cytotoxic T lymphocytes: a potential option for improvement in antigen-specific cancer immunotherapy

by Nobuoka, Daisuke, Yoshikawa, Toshiaki, Takahashi, Mari, Iwama, Tatsuaki, Horie, Kazutaka, Shimomura, Manami, Suzuki, Shiro, Sakemura, Noriko, Nakatsugawa, Munehide, Sadamori, Hiroshi, Yagi, Takahito, Fujiwara, Toshiyoshi, Nakatsura, Tetsuya
Published 2012

Identification of HLA-A2 or HLA-A24-restricted CTL epitopes for potential HSP105-targeted immunotherapy in colorectal cancer

by SAWADA, YU, KOMORI, HIROYUKI, TSUNODA, YOSHIYUKI, SHIMOMURA, MANAMI, TAKAHASHI, MARI, BABA, HIDEO, ITO, MASAAKI, SAITO, NORIO, KUWANO, HIROYUKI, ENDO, ITARU, NISHIMURA, YASUHARU, NAKATSURA, TETSUYA
Published 2014

Hepatocellular carcinoma cell sensitivity to Vγ9Vδ2 T lymphocyte-mediated killing is increased by zoledronate

by SUGAI, SHIORI, YOSHIKAWA, TOSHIAKI, IWAMA, TATSUAKI, TSUCHIYA, NOBUHIRO, UEDA, NORIHIRO, FUJINAMI, NORIHIRO, SHIMOMURA, MANAMI, ZHANG, RONG, KANEKO, SHIN, UEMURA, YASUSHI, NAKATSURA, TETSUYA
Published 2016